Philippines Launches Major Ivermectin Clinical Trial to Investigate Efficacy During Unprecedented Spike in Case in the Southeast Asian Nation

Philippines Launches Major Ivermectin Clinical Trial to Investigate Efficacy During Unprecedented Spike in Case in the Southeast Asian Nation

A senior government official in the Philippines announced the launch of a major clinical trial investigating several drugs including ivermectin, the anti-parasite medication used frequently in the tropics, in patients with COVID-19 in a quest to determine safety and efficacy. While ivermectin has grown in popularity here as an off-label treatment for COVID-19, the majority of world drug regulators and government research bodies believe the existing clinical trial data isn’t sufficient for any emergency use authorization declaration.  That’s the same here in the Philippines as the food and drug regulator in this Southeastern Asian nation cautions against use for the SARS-CoV-2 indication due to the lack of evidence. Fortunato de la Pena, the nation’s science and technology minister, declared in a presentation Monday that the ivermectin-focused clinical trial “will give us a more reliable estimate of the effects of ivermectin as an antiviral agent in mild and moderate (COVID-19) patients.”

COVID-19 Surge

With over 945,000 COVID-19 cases and more than 16,000 deaths, this country is on the edge as early on its didn’t face that great of a disruption from the pandemic—unlike countries in North and South America and Europe. TrialSite earlier this month reported on the growing problems wrought by the pandemic in the Southeast Asian nation. With a surge of SARS-CoV-2 infections and a vaccination drive totaling 1.3 million, the nation’s leadership faces an uphill battle when factoring in their total population of 108 million. Hence the growing interest in ivermectin and the request of hospitals for access to the drug for compassionate use

A Range of Investigational Candidates

This large platform-type trial will investigate not only ivermectin but also, according to de la Pena, a novel formulation of the steroid methylprednisolone and melatonin as a treatment for SARS-CoV-2, the virus behind COVID-19. According to a Reuters report, the government also looks into local herbal supplements as a care option. Apparently, this product is derived from a native plant called tawa-tawa used to treat dengue as well as create virgin coconut oil. With a goal to try anything with a chance of helping, de la Pena declared, “We are trying several medications. They may not be vaccines but they could potentially speed up the recovery.”


This site uses Akismet to reduce spam. Learn how your comment data is processed.

  1. It’s great to see a government trying to see what could help the suffering of their people. It’s unfortunate that they didn’t start this trail much sooner. There are many cheap therapeutics that look promising and could provide significant benefits when given early. I’d recommend they include the following in their trial: ivermectin, fluvoxamine, ciclesonide, cholecalciferol (at symptom onset) or calcifediol (at admission), Losartan (or other ARB), statins, aspirin, famotidine, GSH, NAC, and Lactoferrin. There are other promising therapeutics but these have a combination of promising data, widely available, inexpensive, and excellent safety profiles.

  2. Is this not enough proof ?

    WHO ivermectin approval status
    Indication Studies Patients Effect size Status
    Scabies [Kory (B)] 6 613 35% [22‑46%] (favoring permethrin) Approved
    COVID‑19 52 17,562 72% [ 64‑78%] Pending
    Sure… I’m biased towards common sense,
    So why is ivermectin not used accross the world by now eh ??